Detalles de la búsqueda
1.
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance.
Int J Mol Sci
; 22(24)2021 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34948316
2.
Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing.
Int J Mol Sci
; 22(2)2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33418877
3.
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.
Mol Ther Oncol
; 32(1): 200760, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596303
4.
The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties.
Sci Rep
; 13(1): 19541, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37945588
5.
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC.
Cancers (Basel)
; 14(21)2022 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358708
6.
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.
Cancers (Basel)
; 14(5)2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267633
7.
Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments.
Cancers (Basel)
; 13(12)2021 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34201082
8.
Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC.
Cancers (Basel)
; 14(1)2021 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008285
9.
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells.
Cancers (Basel)
; 12(8)2020 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32781690
10.
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus.
Cancers (Basel)
; 12(11)2020 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213060
11.
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis.
Sci Rep
; 10(1): 4307, 2020 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152425
12.
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment.
Mol Ther Oncolytics
; 19: 253-264, 2020 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33209980
13.
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling.
Sci Rep
; 9(1): 13125, 2019 09 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511565
14.
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells.
MAbs
; 10(5): 730-737, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658818
15.
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies.
MAbs
; 10(7): 1060-1072, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29995563
16.
One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1.
Biomed Res Int
; 2015: 703213, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26649313
Resultados
1 -
16
de 16
1
Próxima >
>>